// App-Quantinova.ai

5018 : A phase 3 study in an enriched population of pulmonary arterial hypertension patients with long term oxygen use demonstrating improved exercise tolerance with use of ambulatory inhaled nitric oxide

Researchers

Presenter

  • H.W. Farber

Principal Investigators

  • M.M. Hoeper

  • R.L. Benza

  • M.D. Delcroix

  • J.T. Granton

  • A.J. Peacock

  • P.P. Fernandes

  • K.E. Sartoris

  • D.A. Quinn

Medical Centers

  • Boston University Medical Center, Boston, United States of America

  • Hannover Medical School, Hannover, Germany

  • Allegheny General Hospital, Pittsburgh, United States of America

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • Golden Jubilee National Hospital, Clydebank, United Kingdom

  • Bellerophon Therapeutics, Warren, United States of America

Locations

  • Germany

  • Belgium

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • INO

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Open Label

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved